Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - SolarWindow Technologies, Inc. | exh_321.htm |
| EX-31.2 - EXHIBIT 31.2 - SolarWindow Technologies, Inc. | exh_312.htm |
| EX-31.1 - EXHIBIT 31.1 - SolarWindow Technologies, Inc. | exh_311.htm |
| EX-10.1 - EXHIBIT 10.1 - SolarWindow Technologies, Inc. | exh_101.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
| ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended November 30, 2020
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from ___________ to ___________
Commission file number 333-127953
SOLARWINDOW TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
| Nevada |
59-3509694 | |
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |
| 430 Park Avenue, Suite 702 | ||
| New York, NY | 10022 | |
| (Address of principal executive offices) | (Zip Code) |
(800) 213-0689
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☐ | Accelerated filer | ☐ | |
| Non-accelerated filer | ☒ |
Smaller reporting company |
☒ | |
| Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in 12b-2 of the Exchange Act). Yes ☐ No ☒
Securities registered pursuant to Section 12(b) of the Act: None
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 52,964,990 shares of common stock, par value $0.001, were outstanding on January 6, 2021.
SOLARWINDOW TECHNOLOGIES, INC.
FORM 10-Q
For the Quarterly Period Ended November 30, 2020
Table of Contents
PART I — FINANCIAL INFORMATION
Item 1. Consolidated Financial Statements
SOLARWINDOW TECHNOLOGIES, INC.
CONSOLIDATED BALANCE SHEETS
| November 30, | August 31, | |||||||
| 2020 | 2020 | |||||||
| ASSETS | (Unaudited) | |||||||
| Current assets | ||||||||
| Cash and cash equivalents | $ | 8,549,510 | $ | 14,151,523 | ||||
| Short-term investments | 5,000,000 | - | ||||||
| Deferred research and development costs | 463,614 | 574,731 | ||||||
| Prepaid expenses and other current assets | 20,962 | 56,147 | ||||||
| Total current assets | 14,034,086 | 14,782,401 | ||||||
| Operating lease right-of-use asset | - | 42,212 | ||||||
| Property and equipment, net of accumulated depreciation of $88,498 and $93,323, respectively | 1,360,503 | 1,349,495 | ||||||
| Security deposit | 13,537 | 2,200 | ||||||
| Total assets | 15,408,126 | 16,176,308 | ||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
| Current liabilities | ||||||||
| Accounts payable and accrued expenses | 64,256 | 53,428 | ||||||
| Related party payables | 71,967 | 113,186 | ||||||
| Current maturities of operating lease | - | 24,828 | ||||||
| Total current liabilities | 136,223 | 191,442 | ||||||
| Non-current operating lease | - | 17,737 | ||||||
| Total long term liabilities | - | 17,737 | ||||||
| Total liabilities | 136,223 | 209,179 | ||||||
| Commitments and contingencies | ||||||||
| Stockholders' equity | ||||||||
| Preferred stock: $0.10 par value; 1,000,000 shares authorized, no shares issued and outstanding | - | - | ||||||
| Common stock: $0.001 par value; 300,000,000 shares authorized, 52,959,323 shares issued and outstanding at November 30, 2020 and August 31, 2020 | 52,959 | 52,959 | ||||||
| Additional paid-in capital | 77,877,741 | 76,039,209 | ||||||
| Accumulated other comprehensive income (loss) | 3,277 | - | ||||||
| Retained deficit | (62,662,074 | ) | (60,125,039 | ) | ||||
| Total stockholders' equity | 15,271,903 | 15,967,129 | ||||||
| Total liabilities and stockholders' equity | $ | 15,408,126 | $ | 16,176,308 | ||||
(The accompanying notes are an integral part of these consolidated financial statements)
| 1 |
SOLARWINDOW TECHNOLOGIES, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
| Three Months Ended November 30, | ||||||||
| 2020 | 2019 | |||||||
| Revenue | $ | - | $ | - | ||||
| Operating expenses | ||||||||
| Selling, general and administrative | 1,999,785 | 620,781 | ||||||
| Research and development | 547,864 | 579,000 | ||||||
| Total operating expenses | 2,547,649 | 1,199,781 | ||||||
| Loss from operations | (2,547,649 | ) | (1,199,781 | ) | ||||
| Other income (expense) | ||||||||
| Interest income | 19,389 | 94,503 | ||||||
| Loss on disposal of assets | (8,775 | ) | - | |||||
| Total other income (expense) | 10,614 | 94,503 | ||||||
| Net loss | $ | (2,537,035 | ) | $ | (1,105,278 | ) | ||
| Basic and Diluted Loss per Common Share | $ | (0.05 | ) | $ | (0.02 | ) | ||
| Weighted average number of common shares outstanding - basic and diluted | 52,959,323 | 52,959,323 | ||||||
(The accompanying notes are an integral part of these consolidated financial statements)
| 2 |
SOLARWINDOW TECHNOLOGIES, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
| Three Months Ended November 30, | ||||||||
| 2020 | 2019 | |||||||
| Net income (loss) | $ | (2,537,035 | ) | $ | (1,105,278 | ) | ||
| Other comprehensive income (loss): | ||||||||
| Foreign currency translation adjustments | 3,277 | - | ||||||
| Comprehensive income (loss) | $ | (2,533,758 | ) | $ | (1,105,278 | ) | ||
(a) Amounts include gains from the strengthening of the South Korean Won against the U.S. dollar.
(The accompanying notes are an integral part of these consolidated financial statements)
| 3 |
SOLARWINDOW TECHNOLOGIES, INC.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED)
Accumulated Other | Total ' | |||||||||||||||||||||||
| Common Stock | Additional | Retained | Comprehensive | Stockholders | ||||||||||||||||||||
| FOR THE THREE MONTHS ENDED NOVEMBER 30, 2020 | Shares | Amount | Paid-in Capital | Deficit | Income | Equity | ||||||||||||||||||
| Balance, August 31, 2020 | 52,959,323 | 52,959 | 76,039,209 | (60,125,039 | ) | - | 15,967,129 | |||||||||||||||||
| Stock based compensation due to common stock purchase options | - | - | 1,838,532 | - | - | 1,838,532 | ||||||||||||||||||
| Foreign currency translation adjustments | - | - | - | - | 3,277 | 3,277 | ||||||||||||||||||
| Net loss for the three months ended November 30, 2020 | - | - | - | (2,537,035 | ) | - | (2,537,035 | ) | ||||||||||||||||
| 52,959,323 | $ | 52,959 | $ | 77,877,741 | $ | (62,662,074 | ) | $ | 3,277 | $ | 15,271,903 | |||||||||||||
Accumulated Other | Total ' | |||||||||||||||||||||||
| Common Stock | Additional | Retained | Comprehensive | Stockholders | ||||||||||||||||||||
| FOR THE THREE MONTHS ENDED NOVEMBER 30, 2019 | Shares | Amount | Paid-in Capital | Deficit | Income | Equity | ||||||||||||||||||
| Balance, August 31, 2019 | 52,959,323 | $ | 52,959 | $ | 71,166,300 | $ | (52,771,977 | ) | $ | - | $ | 18,447,282 | ||||||||||||
| Stock based compensation due to common stock purchase options | - | - | 420,970 | - | - | 420,970 | ||||||||||||||||||
| Net loss for the three months ended November 30, 2019 | - | - | - | (1,105,278 | ) | - | (1,105,278 | ) | ||||||||||||||||
| Balance, November 30, 2019 | 52,959,323 | $ | 52,959 | $ | 71,587,270 | $ | (53,877,255 | ) | $ | - | $ | 17,762,974 | ||||||||||||
(The accompanying notes are an integral part of these consolidated financial statements)
| 4 |
SOLARWINDOW TECHNOLOGIES, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
| Three Months Ended November 30, | ||||||||
| 2020 | 2019 | |||||||
| Cash flows from operating activities | ||||||||
| Net loss | $ | (2,537,035 | ) | $ | (1,105,278 | ) | ||
| Adjustments to reconcile net loss to net cash flows used in operating activities | ||||||||
| Depreciation | 5,782 | 6,684 | ||||||
| Stock based compensation expense | 1,838,532 | 420,970 | ||||||
| Loss on disposal of assets | 8,775 | - | ||||||
| Changes in operating assets and liabilities: | ||||||||
| Deferred research and development costs | 111,117 | (77,706 | ) | |||||
| Prepaid expenses and other assets | 35,185 | 20,047 | ||||||
| Accounts payable and accrued expenses | 10,792 | 25,700 | ||||||
| Operating lease assets and liabilities | (353 | ) | 68 | |||||
| Related party payable | (41,219 | ) | 61,047 | |||||
| Security deposits | (10,890 | ) | - | |||||
| Net cash flows used in operating activities | (579,314 | ) | (648,468 | ) | ||||
| Cash flows used in investing activity | ||||||||
| Purchaseof short-term investments | (5,000,000 | ) | - | |||||
| Capital expenditures | (27,726 | ) | (5,031 | ) | ||||
| Proceeds from the sale of assets | 2,161 | - | ||||||
| Net cash flows used in investing activity | (5,025,565 | ) | (5,031 | ) | ||||
| Effect of exchange rate changes on cash and cash equivalents | 2,866 | - | ||||||
| Net increase (decrease) in cash and cash equivalents | (5,602,013 | ) | (653,499 | ) | ||||
| Cash and cash equivalents at beginning of period | 14,151,523 | 16,604,011 | ||||||
| Cash and cash equivalents at end of period | $ | 8,549,510 | $ | 15,950,512 | ||||
| Supplemental disclosure of cash flow information: | ||||||||
| Interest paid in cash | $ | - | $ | - | ||||
| Income taxes paid in cash | $ | - | $ | - | ||||
(The accompanying notes are an integral part of these consolidated financial statements)
| 5 |
SOLARWINDOW TECHNOLOGIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
NOTE 1 – Basis of Presentation and Organization
Basis of Presentation
The accompanying unaudited interim consolidated financial statements of SolarWindow Technologies, Inc. (the “Company”) as of November 30, 2020, and for the three months ended November 30, 2020 and 2019 have been prepared in accordance with accounting principles generally accepted in the United States (“U.S.”) of America, or U.S. GAAP, for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted.
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of expenses during the reporting periods. Actual results may differ from those estimates. The interim consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended August 31, 2020. The accompanying unaudited interim consolidated financial statements have been prepared on the same basis as the audited financial statements and include all adjustments (including normal recurring adjustments) necessary for the fair presentation of the Company’s consolidated financial position as of November 30, 2020, results of operations, stockholders’ equity and cash flows for the three months ended November 30, 2020 and 2019. The Company did not record an income tax provision during the periods presented due to net taxable losses. The results of operations for any interim period are not necessarily indicative of the results of operations for the entire year.
Organization
SolarWindow Technologies, Inc. was incorporated in the State of Nevada on May 5, 1998. Products derived from the Company’s SolarWindow™ technology harvest light energy from the sun and from artificial light sources, by generating electricity from a transparent coating of organic photovoltaic (“OPV”) solar cells, applied to glass and plastics, thereby creating a “photovoltaic” effect. The Company’s ticker symbol is WNDW.
Liquidity and Management’s Plan
The Company does not have any commercialized products, has not generated any revenue since inception and has sustained recurring losses and negative cash flows from operations since inception. Due to the “start-up” nature of our business, we expect to incur losses as we continue development of our products and technologies. As of November 30, 2020, the Company had $13,549,510 of cash and cash equivalents and short term investments on hand and working capital of $13,897,863. The Company believes that it currently has sufficient cash to meet its funding requirements over the next twelve months following the issuance of this Quarterly Report on Form 10-Q. However, the Company has experienced and continues to experience negative cash flows from operations, as well as an ongoing requirement for substantial additional capital investment. The Company expects that it may need to raise additional capital to accomplish its business plan. If additional funding is required, the Company expects to seek to obtain that funding through financial or strategic investors. There can be no assurance as to the availability or terms upon which such financing and capital might be available.
NOTE 2 – Summary of Significant Accounting Policies
Information regarding the Company’s significant accounting policies is contained in Note 2, “Summary of significant accounting policies,” to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended August 31, 2020. Presented below and in the following notes is supplemental information that should be read in conjunction with “Notes to Financial Statements” in the Annual Report.
| 6 |
Fiscal quarter
The Company’s quarterly periods end on November 30, February 28, May 31, and August 31. The Company’s first quarter in fiscal 2021 and 2020 ended on November 30, 2020 and 2019, respectively.
Principles of consolidation
On August 24, 2020, the Company formed wholly owned SolarWindow Asia (USA) Corp. as the holding company for SolarWindow Asia Co. Ltd., a company formed in the Republic of Korea for the purpose of expansion into the Asian markets. As of August 31, 2020, the Company had not capitalized the Korean subsidiaries and there were no transactions related to these entities during the year ended August 31, 2020. During our fiscal quarter ended November 30, 2020, the Company capitalized SolarWindow Asia Co. Ltd. with a transfer of $831,000.
These consolidated financial statements presented are those of SolarWindow Technologies, Inc. and its wholly owned subsidiaries, SolarWindow Asia (USA) Corp., and SolarWindow Asia Co. Ltd. All significant intercompany balances and transactions have been eliminated.
Use of estimates
The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the accounting period. The Company considers its accounting policies relating to stock based compensation to be the most significant accounting policy that involves management estimates and judgments. The Company has made accounting estimates based on the facts and circumstances available as of the reporting date. Actual amounts could differ from these estimates, and such differences could be material.
Cash and Cash Equivalents
Cash and cash equivalents include cash on hand and highly liquid investments with original maturities of three months or less from the date of purchase.
| November 30, 2020 | August 31, 2020 | |||||||
| Cash and cash equivalents | 8,549,510 | 14,151,523 | ||||||
| Short-term investment | 5,000,000 | - | ||||||
| Cash and cash equivalents | 13,549,510 | 14,151,523 | ||||||
Short-term investments
The Company determines the balance sheet classification of its investments at the time of purchase and evaluates the classification at each balance sheet date. Money market funds, certificates of deposit, and time deposits with maturities of greater than three months but no more than twelve months are carried at cost, which approximates fair value and are recorded in the consolidated balance sheets in short-term investments. As of November 30, 2020, the short-term investment consists of a fixed-term deposit with a twelve month maturity at the time of purchase on October 1, 2020.
Recent accounting pronouncements not yet adopted
In December 2019, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2019-12, Income Taxes – Simplifying the Accounting for Income Taxes. The guidance removes certain exceptions for recognizing deferred taxes for equity method investments, performing intra period allocation, and calculating income taxes in interim periods. The ASU also adds guidance to reduce complexity in certain areas, including recognizing deferred taxes for goodwill and allocating taxes to members of a consolidated group, among others. This guidance is effective for interim and annual reporting periods beginning after December 15, 2020. Early adoption of the standard is permitted, including adoption in interim or annual periods for which financial statements have not yet been issued. The transition requirements are dependent upon each amendment within this update and will be applied either prospectively or retrospectively. The adoption of ASU 2019-12 is not expected to have a material impact on the Company’s consolidated financial position, results of operations, or cash flows.
| 7 |
Recently adopted accounting pronouncements
The Company reviews new accounting standards as issued. Although some of these accounting standards issued or effective after the end of the Company’s previous fiscal year may be applicable, the Company has not identified any standards that the Company believes merit further discussion. The Company believes that none of the new standards will have a significant impact on the consolidated financial statements.
NOTE 3 – Property and Equipment
Property and equipment consists of the following:
| November 30, | August 31, | |||||||
| 2020 | 2019 | |||||||
| Computers, office equipment and software | $ | 14,800 | $ | 23,709 | ||||
| Furniture and fixtures | 27,726 | 12,634 | ||||||
| Product development and manufacturing equipment | 113,820 | 113,820 | ||||||
| In-process equipment | 1,292,655 | 1,292,655 | ||||||
| Total property and equipment | 1,449,001 | 1,442,818 | ||||||
| Accumulated depreciation | (88,498 | ) | (93,323 | ) | ||||
| Property and equipment, net | $ | 1,360,503 | $ | 1,349,495 | ||||
During the three months ended November 30, 2020 and 2019, the company purchased $27,726 and $5,031 of property and equipment, respectively. During the three months ended November 30, 2020 and 2019, the Company recognized depreciation expense of $5,782 and $6,684, respectively.
As a result of the closure of the Vestal New York office, during the three months ended November 30, 2020, the Company disposed of office equipment, computers and furniture with an historical cost totaling $21,543 and net book value of 10,936. The Company received $2,161 of proceeds from the sale of the assets resulting in a loss of $8,775.
NOTE 4 – Common Stock and Warrants
Common Stock
At November 30, 2020, the Company had 300,000,000 authorized shares of common stock with a par value of $0.001 per share, 52,959,323 shares of common stock outstanding and 6,001,169 shares reserved for issuance under the Company’s 2006 Long-Term Incentive Plan (the “2006 Plan”) as adopted and approved by the Company’s Board on October 10, 2006 that provides for the grant of stock options to employees, directors, officers and consultants. See “NOTE 5 - Stock Options” for additional information.
Warrants
Each of the Company’s warrants outstanding entitles the holder to purchase one share of the Company’s common stock for each warrant share held. Other than the Series O Warrants and Series P Warrants, all of the following warrants may be exercised on a cashless basis. A summary of the Company’s warrants outstanding and exercisable as of November 30, 2020 and August 31, 2019 is as follows:
| 8 |
| Shares of Common Stock Issuable from Warrants Outstanding as of | Weighted Average | |||||||||||||||
| November 30, | August 31, | Exercise | Date of | |||||||||||||
| Description | 2020 | 2019 | Price | Issuance | Expiration | |||||||||||
| Series M | 246,000 | 246,000 | $ | 2.34 | December 7, 2015 | December 31, 2022 | ||||||||||
| Series N | 767,000 | 767,000 | $ | 3.38 | December 31, 2015 | December 31, 2022 | ||||||||||
| Series P | 213,500 | 213,500 | $ | 3.70 | March 25, 2016 | December 31, 2022 | ||||||||||
| Series R | 468,750 | 468,750 | $ | 4.00 | June 20, 2016 | December 31, 2022 | ||||||||||
| Series S-A | 300,000 | 300,000 | $ | 2.53 | July 24, 2017 | December 31, 2022 | ||||||||||
| Series S | 821,600 | 821,600 | $ | 3.42 | September 29, 2017 | September 29, 2022 | ||||||||||
| Series T | 16,666,667 | 16,666,667 | $ | 1.70 | November 26, 2018 | November 26, 2025 | ||||||||||
| Total | 19,483,517 | 19,483,517 | ||||||||||||||
NOTE 5 - Stock Options
Stockholders previously approved 15,000,000 shares for grant under the 2006 Plan. The 2006 Plan was adopted in order to attract and retain the best available personnel for positions of substantial authority and to provide additional incentive to employees and directors to promote the success of the Company’s business. The 2006 Plan provides for the grant of incentive stock options, non-qualified stock options, restricted stock, restricted stock units, stock appreciation rights, and other types of awards to employees, consultants, and directors. Stock option grants pursuant to the 2006 Plan vest either immediately or over zero to five years and expire from six to ten years after the date of grant with the exercise price equal to the fair value of the underlying stock on the date of grant. All shares approved for grant and subsequently forfeited are available for future grant. The Company does not repurchase shares to fulfill the requirements of options that are exercised and therefore issues new shares when options are exercised. The 2006 Plan was approved by stockholders on February 7, 2011 and expires according to its terms on February 7, 2021.
The Company measures share-based compensation cost on the grant date, based on the fair value of the award, and recognizes the expense on a straight-line basis over the requisite service period for awards expected to vest. The Company estimated the grant date fair value of stock options using a Black-Scholes valuation model using the following weighted-average assumptions:
| Three Months Ended November 30, | ||||||||
| 2020 | 2019 | |||||||
| Expected dividend yield | – | – | ||||||
| Expected stock price volatility | 89.44% | 82.94 | – | 86.23% | ||||
| Risk-free interest rate | 0.19% | 1.40 | – | 1.69% | ||||
| Expected term (in years)(simplified method) | 4.00 | 4.5 | – | 5.75 | ||||
| Exercise price | $3.42 | $2.32 | and | $3.54 | ||||
| Weighted-average grant date fair-value | $2.16 | $1.61 | and | $1.55 | ||||
| 9 |
A summary of the Company’s stock option activity for the three months ended November 30, 2020 and related information follows:
| Number of Shares Subject to Option Grants | Weighted Average Exercise Price ($) | Weighted Average Remaining Contractual Term (years) | Aggregate Intrinsic Value ($) | |||||||||||||
| Outstanding at August 31, 2019 | 2,777,334 | 4.31 | ||||||||||||||
| Grants | 5,158,000 | 4.06 | ||||||||||||||
| Forfeitures and cancellations | (130,600 | ) | 3.54 | |||||||||||||
| Outstanding at August 31, 2020 | 7,804,734 | 4.16 | ||||||||||||||
| Grants | 50,000 | 3.42 | ||||||||||||||
| Forfeitures and cancellations | (37,500 | ) | 3.54 | |||||||||||||
| Outstanding at November 30, 2020 | 7,817,234 | 4.16 | 5.29 | 27,557,385 | ||||||||||||
| Exercisable at November 30, 2020 | 3,956,434 | 3.66 | 6.30 | 15,789,872 | ||||||||||||
The aggregate intrinsic value in the table above represents the total pretax intrinsic value for all “in-the-money” options (i.e. the difference between the Company’s closing stock price on the last trading day of the period covered by this report and the exercise price, multiplied by the number of shares) that would have been received by the option holders had all in-the-money option holders exercised their vested options on November 30, 2020. The intrinsic value of the option changes based upon the fair market value of the Company’s common stock. Since the closing stock price was $7.65 on November 30, 2020 and 6,386,567 outstanding options have an exercise price below $7.65 per share, as of November 30, 2020, there is $25,886,685 and $14,070,872 of intrinsic value to the totality of the Company’s outstanding stock options and vested options, respectively.
Three Months Ended November 30, 2020
On October 19, the Company’s Board granted 50,000 options to Joseph Sierchio, Director, with an exercise price of $3.42, exercisable on a cashless basis any time prior to the Company’s listing of any of its securities for trading on a national stock exchange, six year term and vesting at the rate of 12,500 on the date of grant and 12,500 each anniversary thereafter.
Three Months Ended November 30, 2019
On October 9, 2019, the Company granted 153,000 options to an employee with a ten-year term, exercise price of $2.32 per share and vesting at the rate of 1/36th per month. Additionally, on September 16, 2019, the Board granted 5,000 options with a six-year term to a consultant with an exercise price of $3.54 per share and vesting at the rate of 1/20th per quarter.
The following table sets forth the share-based compensation cost resulting from stock option grants, including those previously granted and vesting over time, that were recorded in the Company’s Statements of Operations for the three months ended November 30, 2020 and 2019:
| Three Months Ended November 30, | ||||||||
| 2020 | 2019 | |||||||
| Stock Compensation Expense: | ||||||||
| SG&A | $ | 1,533,824 | $ | 172,219 | ||||
| R&D | 304,708 | 248,751 | ||||||
| Total | $ | 1,838,532 | $ | 420,970 | ||||
As of November 30, 2020, the Company had $5,297,826 of unrecognized compensation cost related to unvested stock options which is expected to be recognized over a period of 3.75 years.
| 10 |
The following table summarizes information about stock options outstanding and exercisable at November 30, 2020:
| Stock Options Outstanding | Stock Options Exercisable | |||||||||||||||||||||||||
| Range of Exercise Prices | Number of Shares Subject to Outstanding Options | Weighted Average Contractual Life (years) | Weighted Average Exercise Price ($) | Number of Shares Subject To Options Exercise | Weighted Average Remaining Contractual Life (Years) | Weighted Average Exercise Price ($) | ||||||||||||||||||||
| 2.32 | 153,000 | 8.86 | 2.32 | 55,250 | 8.86 | 2.32 | ||||||||||||||||||||
| 2.60 | 2,500,000 | 5.59 | 2.60 | 1,250,000 | 5.59 | 2.60 | ||||||||||||||||||||
| 3.28 | 7,500 | 5.96 | 3.28 | 7,500 | 5.96 | 3.28 | ||||||||||||||||||||
| 3.42 | 50,000 | 5.89 | 3.42 | 12,500 | 5.89 | 3.42 | ||||||||||||||||||||
| 3.46 | 35,000 | 5.10 | 3.46 | 35,000 | 5.10 | 3.46 | ||||||||||||||||||||
| 3.54 | 1,342,900 | 7.61 | 3.54 | 1,140,350 | 8.14 | 3.54 | ||||||||||||||||||||
| 3.66 | 1,000,000 | 2.75 | 3.66 | 500,000 | 2.75 | 3.66 | ||||||||||||||||||||
| 4.87 | 187,500 | 6.98 | 4.87 | 187,500 | 6.98 | 4.87 | ||||||||||||||||||||
| 5.35 | 1,008,000 | 7.09 | 5.35 | 735,000 | 7.09 | 5.35 | ||||||||||||||||||||
| 5.94 | 33,334 | 0.06 | 5.94 | 33,334 | 0.06 | 5.94 | ||||||||||||||||||||
| 6.00 | 800,000 | 2.75 | 6.00 | - | 2.75 | 6.00 | ||||||||||||||||||||
| 8.00 | 700,000 | 2.75 | 8.00 | - | 2.75 | 8.00 | ||||||||||||||||||||
| Total | 7,817,234 | 5.29 | 4.16 | 3,956,434 | 6.30 | 3.66 | ||||||||||||||||||||
NOTE 6 – Lease
On May 1, 2019, the Company leased office space in Vestal, New York and entered into a Professional Building Lease Agreement (the “Lease”). The Lease has an initial term of three years through May 1, 2022 with monthly rent due of $2,200 for the first two years and $2,266 during year three. On November 30, 2020, the Company terminated the Lease and entered into a lease termination agreement (the “Termination Agreement”). Pursuant to the terms of the Termination Agreement, the Company made a payment of $26,400 and delivered the premises in good order including the removal of furniture and fixtures which the Company disposed, See “NOTE 3 – Property and Equipment” for additional information related to the disposal of the furniture and fixtures. All related assets and liabilities were written off with $418 of unrecognized interest expense charged to rent expense.
As of November 30, 2020, the Company has not entered into any leases which have not yet commenced which would entitle the Company to significant rights or create additional obligations.
The components of Lease expenses are as follows:
| Three Months Ended November 30, 2020 | ||||||||
| 2020 (a) | 2019 | |||||||
| Operating lease cost | $ | 32,648 | $ | 6,666 | ||||
| Short-term lease costs | - | - | ||||||
| Total net lease costs | $ | 32,648 | $ | 6,666 | ||||
(a) Represents 3 months of rent expense at $2,222 per month, $26,400 lease termination fee and ($418) of unrecognized interest expense.
| 11 |
Supplemental balance sheet information related to the Lease is as follows:
| November 30, | August 31, | |||||||
| 2020 | 2019 | |||||||
| Operating lease right-of-use asset | $ | - | $ | 42,212 | ||||
| Current maturities of operating lease | $ | - | $ | 24,828 | ||||
| Non-current operating lease | - | 17,736 | ||||||
| Total operating lease liabilities | $ | - | $ | 42,564 | ||||
| Weighted Average remaining lease term (in years): | - | 1.67 | ||||||
| Discount rate: | - | 5.85 | % | |||||
In September 2020, the Company, through its wholly owned subsidiaries, SolarWindow Asia (USA) Corp. and SolarWindow Asia Co., Ltd., entered a lease for office space in South Korea. The lease has a term of one year from September 23, 2020 through September 23, 2021 with monthly payments of approximately $1,200.
NOTE 7 - Transactions with Related Persons
A related party with respect to the Company is generally defined as any person (i) (and, if a natural person, inclusive of his or her immediate family) that holds 10% or more of the Company’s securities, (ii) that is part of the Company’s management, (iii) that directly or indirectly controls, is controlled by or is under common control with the Company, or (iv) who can significantly influence the financial and operating decisions of the Company. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.
On August 7, 2017, the Company appointed Jatinder Bhogal to the Board of Directors. Mr. Bhogal has provided consulting services to the Company through his wholly owned company, Vector Asset Management, Inc., pursuant to a Consulting Agreement dated February 1, 2014, as amended on November 11, 2016 and December 1, 2018 (Amendment No. 2). On July 1, 2020 the Company and VAMI entered into an Executive Consulting Agreement, which supersedes the foregoing agreements and pursuant to which Mr. Bhogal, in addition to continuing to serve as a director of the Company will also serve as the Company’s President and Chief Executive Officer. Pursuant to the Consulting Agreements in effect prior to December 1, 2018, Mr. Bhogal received compensation of $5,000 per month. Beginning with Amendment No. 2, Mr. Bhogal received compensation of $18,750 per month and pursuant to the ECA, Mr. Bhogal receives $34,167 per month. Mr. Bhogal also incurs expenses on behalf of the Company which are reimbursed according to the Company’s expense report policy. The Company recognized cash compensation expense in connection with the Consulting Agreements and ECA of $102,500 and $56,250 during the three months ended November 30, 2020 and 2019, respectively. As of November 30, 2020, the Company recognized a related party payable to Mr. Bhogal of $34,167.
During the three months ended November 30, 2020 and 2019, the Company received advances of $0 and $73,005, respectively, from Talia Jevan Properties, Inc., a British Columbia corporation wholly-owned by our former Chairman and majority shareholder, Harmel S. Rayat. The Company repaid Talia Jevan Properties $53,251 and $0 during the three months ended November 30, 2020 and 2019. As of November 30, 2020, there were no balances owing to Talia Jevan Properties, Inc.
Joseph Sierchio, one of the Company’s directors, has maintained his role as the Company’s General Counsel since its inception as Principal of the law firm of Sierchio & Partners, LLP, and then as a Partner with Satterlee Stephens LLP and beginning in August 2020, as Principal of Sierchio Law, LLP pursuant to an engagement letter which provides for an annual fee of $175,000 in exchange for general counsel services. Mr. Sierchio resigned from the Board effective October 22, 2018, and was reappointed on October 1, 2020. During the three months ended November 30, 2020 and 2019, the Company recognized $43,750 and $43,750 of fees for legal services billed by Sierchio Law, LLP.
All related party transactions are recorded at the exchange amount established and agreed to between related parties and are in the normal course of business.
| 12 |
NOTE 8 – Commitments and Contingencies
In September 2020, the Company, through its wholly owned subsidiaries, SolarWindow Asia (USA) Corp. and SolarWindow Asia Co., Ltd., entered a lease for office space in South Korea. The lease has a term of one year from September 23, 2020 through September 23, 2021 with monthly payments of approximately $1,200.
During 2019 the Company made payments totaling $1,292,655 towards the purchase of manufacturing equipment with an estimated total cost of $1,803,000. The remaining $510,345 will be paid upon the completion of the equipment once the final specifications have been determined pending optimization of the Company’s product iteration specific to this equipment. For additional information, see “Note 3 – Property and Equipment” located in the footnotes to our financial statements.
COVID-19
In December 2019, an outbreak of the COVID-19 virus was reported in Wuhan, China. On March 11, 2020, the World Health Organization declared the COVID-19 virus a global pandemic and on March 13, 2020, President Donald J. Trump declared the virus a national emergency in the United States. This highly contagious disease has spread to most of the countries in the world and throughout the United States, creating a serious impact on customers, workforces and suppliers, disrupting economies and financial markets, and potentially leading to a world-wide economic downturn. It has caused a disruption of the normal operations of many businesses, including the temporary closure or scale-back of business operations and/or the imposition of either quarantine or remote work or meeting requirements for employees, either by government order or on a voluntary basis. The pandemic may adversely affect our operations, our employees and our employee productivity. It may also impact the ability of our subcontractors, partners, and suppliers to operate and fulfill their contractual obligations, and result in an increase in costs, delays or disruptions in performance. Our employees are working remotely and using various technologies to perform their functions. In reaction to the spread of COVID-19 in the United States, many businesses have instituted social distancing policies, including the closure of offices and worksites and deferring planned business activity. The disruption and volatility in the global and domestic capital markets may increase the cost of capital and limit our ability to access capital. Both the health and economic aspects of the COVID-19 virus are highly fluid and the future course of each is uncertain. For these reasons and other reasons that may come to light if the coronavirus pandemic and associated protective or preventative measures expand, we may experience a material adverse effect on our business operations, revenues and financial condition; however, its ultimate impact is highly uncertain and subject to change.
NOTE 9 - Net Income (Loss) Per Share
The computation of basic earnings per share (“EPS”) is based on the weighted average number of shares that were outstanding during the period, including shares of common stock that are issuable at the end of the reporting period. The computation of diluted EPS is based on the number of basic weighted-average shares outstanding plus the number of common shares that would be issued assuming the exercise of all potentially dilutive common shares outstanding using the treasury stock method. The computation of diluted net income per share does not assume conversion, exercise or contingent issuance of securities that would have an antidilutive effect on earnings per share. Therefore, when calculating EPS if the Company experienced a loss, there is no inclusion of dilutive securities as their inclusion in the EPS calculation is antidilutive. Furthermore, options and warrants will have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options or warrants (they are in the money).
| 13 |
Following is the computation of basic and diluted net loss per share for the three months ended November 30, 2020 and 2019:
| Three Months Ended November 30, | ||||||||
| 2020 | 2019 | |||||||
| Basic and Diluted EPS Computation | ||||||||
| Numerator: | ||||||||
| Loss available to common stockholders' | $ | (2,537,035 | ) | $ | (1,105,278 | ) | ||
| Denominator: | ||||||||
| Weighted average number of common shares outstanding | 52,959,323 | 52,959,323 | ||||||
| Basic and diluted EPS | $ | (0.05 | ) | $ | (0.02 | ) | ||
| The shares listed below were not included in the computation of diluted losses per share because to do so would have been antidilutive for the periods presented: | ||||||||
| Stock options | 7,817,234 | 2,935,334 | ||||||
| Warrants | 19,483,517 | 19,483,517 | ||||||
| Total shares not included in the computation of diluted losses per share | 27,300,751 | 22,418,851 | ||||||
NOTE 10 – Subsequent Events
Management has reviewed material events subsequent of the period ended November 30, 2020 and through the date of filing of financial statements in accordance with FASB ASC 855 “Subsequent Events”. In managements opinion, no material subsequent events have occurred as of the date of this quarterly report.
On December 18, 2020, one of our Directors exercised 16,667 stock options on a cashless basis resulting in the issuance of 5,667 shares of restricted common stock.
On December 18, 2020, Mr. John Conklin and the Company entered into an Amendment to the Separation, Consulting and Release of Claims Agreement dated November 24, 2020. Pursuant to the Amendment, no further payments are due to Mr. Conklin and all stock options granted under his employment agreement totaling 1,008,000 are cancelled.
| 14 |
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Forward-Looking Statements
This Report on Form 10-Q contains forward-looking statements which involve assumptions and describe our future plans, strategies, and expectations, and are generally identifiable by use of words such as “may,” “will,“ “should,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” or “project,” or the negative of these words or other variations on these words or comparable terminology. These statements are expressed in good faith and based upon a reasonable basis when made, but there can be no assurance that these expectations will be achieved or accomplished.
Such forward-looking statements include statements regarding, among other things, (a) the potential markets for our technologies, our potential profitability, and cash flows, (b) our growth strategies, (c) expectations from our ongoing research and development activities, (d) anticipated trends in the technology industry, (e) our future financing plans, and (f) our anticipated needs for working capital. This information may involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from the future results, performance, or achievements expressed or implied by any forward-looking statements. These statements may be found under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” as well as in this Form 10-Q generally. Actual events or results may differ materially from those discussed in forward-looking statements as a result of various factors, including, without limitation, the matters described in this Form 10-Q generally. In light of these risks and uncertainties, there can be no assurance that the forward-looking statements contained in this filing will in fact occur. In addition to the information expressly required to be included in this filing, we will provide such further material information, if any, as may be necessary to make the required statements, in light of the circumstances under which they are made, not misleading.
Although forward-looking statements in this report reflect the good faith judgment of our management, forward-looking statements are inherently subject to known and unknown risks, business, economic and other risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this report, other than as may be required by applicable law or regulation. Readers are urged to carefully review and consider the various disclosures made by us in our filings with the Securities and Exchange Commission which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect our actual results may vary materially from those expected or projected.
Except where the context otherwise requires and for purposes of this Form 10-Q only, the terms “we,” “us,” “our,” “Company” “our Company,” and “SolarWindow” refer to SolarWindow Technologies, Inc., a Nevada corporation.
Overview
SolarWindow Technologies, Inc. is a developer of transparent electricity-generating coatings (“LiquidElectricity™ Coatings”). When applied in ultra-thin layers to rigid glass, and flexible glass and plastic surfaces our LiquidElectricity™ Coatings transform otherwise ordinary surfaces into photovoltaic devices capable of generating electricity from natural sun, artificial light, and low, shaded, or reflected light conditions while maintaining transparency.
We have overcome major technical challenges and achieved many important milestones resulting in an expansion of the potential applications of LiquidElectricity™ Coatings. Potential applications of LiquidElectricity™ Coatings span multiple industries, including architectural, automotive, agrivoltaic, aerospace, commercial transportation and marine. Our LiquidElectricity™ Coatings and SolarWindow™ products are under development with support from commercial contract firms and at the U.S. Department of Energy’s National Renewable Energy Laboratory, through Cooperative Research and Development Agreements.
| 15 |
Research and Related Agreements
We are a party to certain agreements related to the development of our SolarWindow™ technology.
Stevenson-Wydler Cooperative Research and Development Agreement with the Alliance for Sustainable Energy
On March 18, 2011, we entered into the NREL CRADA with Alliance for Sustainable Energy, the operator of the NREL under its U.S. Department of Energy contract to advance the commercial development of the SolarWindow™ technology. Under terms of the NREL CRADA, NREL researchers make use of our exclusive intellectual property (“IP”), newly developed IP, and NREL’s background IP in order to work towards specific product development goals, established by the Company. Under the terms of the NREL CRADA, we agreed to reimburse Alliance for Sustainable Energy for filing fees associated with all documented, out-of-pocket costs directly related to patent application preparation and filings, and maintenance of the patent applications.
On March 6, 2013, we entered into Phase II of our NREL CRADA. Under the terms of the agreement, researchers will additionally work towards:
| · | further improving SolarWindow™ technology efficiency and transparency; |
| · | optimizing electrical power (current and voltage) output; |
| · | optimizing the application of the active layer coatings which make it possible for SolarWindow™ coatings to generate electricity on glass surfaces; |
| · | developing improved electricity-generating coatings by enhancing performance, processing, reliability, and durability; |
| · | optimizing SolarWindow™ coating performance on flexible substrates; and |
| · | developing high speed and large area roll-to-roll (R2R) and sheet-to-sheet (S2S) coating methods required for commercial-scale building integrated photovoltaic (“BIPV”) products and windows. |
On December 28, 2015, we entered into another modification to the NREL CRADA (the “Modification”). Under the Modification, (i) the date of completion was extended to December 2019; and (ii) the Company and the NREL will work jointly towards achieving specific product development goals and objectives for the purpose of preparing to commercialize our OPV-based SolarWindow™ transparent electricity-generating coatings for various applications, including BIPV, glass and flexible plastics.
Over the course of our collaborative research and development efforts with the NREL under the CRADA, both parties have agreed to modifications to extend the date of completion. The Company and NREL have entered into eight such No Cost Time Extensions (“NCTE”). Under the terms of each NCTE, all terms and conditions of the NREL CRADA remain in full force and effect without change. The current NCTE was executed on September 15, 2020 and extends the date of completion to December 31, 2021. As of November 30, 2020, the Company had a capitalized asset balance of $463,614 related to deferred research and development costs for advances to Alliance for Sustainable Energy for work to be performed under the NREL CRADA.
U.S. Department of Energy (DOE) Office of Energy Efficiency and Renewable Energy’s (EERE) Advanced Manufacturing Office (AMO) Cooperative Research and Development Agreement
On March 15, 2018 the Company was awarded its first-ever AMM CRADA by the DOE EERE AMO. SolarWindow was awarded the AMM CRADA after submitting a proposal outlining its coating technologies and fabrication methods to the DOE’s Roll-to-Roll Advanced Materials Manufacturing Consortium, led by ORNL and partnering with ANL, LBNL, and NREL. The AMM CRADA will be carried out with the DOE by SolarWindow, ANL, and NREL.
On September 15, 2020, we entered into NCTE that extends the date of completion to December 31, 2021 pursuant to which researchers work towards specific product development goals outlined in the AMM CRADA.
| 16 |
Through the developments of AMM CRADA, the Company accomplished initiatives to improve and optimize its laser patterning system and methods of fabrication for our electricity-generating coatings on flexible plastics. Once optimized for industry, this advancement is expected to reduce process time, improve device performance, and reduce costs of SolarWindow™ electricity-generating plastic products. Another objective of the AMM CRADA is to develop and demonstrate a unique high-throughput process methodology for semitransparent OPV modules compatible with high process speeds for many different advanced material manufacturing systems.
Results of Operations
Our quarterly periods end on November 30, February 28, May 31, and August 31. Our operating results for the fiscal quarter ended November 30, 2020 may not be indicative of the results that may be expected for the fiscal year ending August 31, 2021 because of the COVID-19 pandemic and other potential beneficial or detrimental unforeseen occurrences. In addition, our quarterly results of operations have varied in the past and are likely to do so again in the future. As such, we believe that period-to-period comparisons of our results of operations should not be relied upon as an indication of our future performance.
The following table presents the components of our consolidated results of operations for the periods indicated:
| Three Months Ended | 2021 compared to 2020 | |||||||||||||||
| November 30, | Increase / | Percentage | ||||||||||||||
| 2020 | 2019 | (Decrease) | Change | |||||||||||||
| Operating expenses: | ||||||||||||||||
| Selling, general & administrative | $ | 465,961 | $ | 448,562 | $ | 17,399 | 4 | % | ||||||||
| Research and development | 243,156 | 330,249 | (87,093 | ) | -26 | % | ||||||||||
| Stock compensation | 1,838,532 | 420,970 | 1,417,562 | 337 | % | |||||||||||
| Total Operating expense | $ | 2,547,649 | $ | 1,199,781 | $ | 1,347,868 | 112 | % | ||||||||
Comparison of the three months ended November 30, 2020 to the three months ended November 30, 2019
Selling, General and Administrative
Selling, general and administrative (“SG&A”) costs include all expenditures incurred other than research and development related costs, including costs related to personnel, professional fees, travel and entertainment, public company costs, insurance and other office related costs. During the three months ended November 30, 2020 compared to the three months ended November 30, 2019, SG&A costs increased due primarily to a $92,000 increase in personnel costs and $69,459 increase in other administrative costs offset by a decrease of $144,061 in professional fees.
Research and Development
Research and Development (“R&D”) costs represent costs incurred to develop our SolarWindow™ technology and are incurred pursuant to our research agreements and agreements with other third-party providers and certain internal R&D cost allocations. Payments under these agreements include salaries and benefits for R&D personnel, allocated overhead, contract services and other costs. R&D costs are expensed when incurred, except for non-refundable advance payments for future research and development activities which are capitalized and recognized as expense as the related services are performed. During the three months ended November 30, 2020 compared to the three months ended November 30, 2019, R&D costs decreased as a result of a $51,177 decrease in CRADA costs and $42,502 decrease in other R&D related costs offset by a $6,587 increase in personnel costs.
| 17 |
Stock Based Compensation
The Company grants stock options to its Directors, employees and consultants. Stock compensation represents the expense associated with the amortization of our stock options. Expense associated with equity-based transactions is calculated and expensed in our financial statements as required pursuant to various accounting rules and is non-cash in nature. Stock based compensation expense increased due primarily to the Company entering into an Executive Consulting Agreement with each of Mr. Jatinder S. Bhogal, President and CEO and Mr. John Rhee, Director, pursuant to which each party was granted 2,500,000 stock purchase options in the fourth quarter of last fiscal year.
Other Income (Expense)
A summary of our other income (expense) for the three months ended November 30, 2020 and 2019 follows:
Three Months Ended November 30, | 2021 compared to | |||||||||||
| 2020 | 2019 | 2020 | ||||||||||
| Other income (expense) | ||||||||||||
| Interest income | $ | 19,389 | $ | 94,503 | (75,114 | ) | ||||||
| Loss on disposal of assets | (8,775 | ) | - | 8,775 | ||||||||
| Total other income (expense) | $ | 10,614 | $ | 94,503 | $ | (66,339 | ) | |||||
| Total other income (expense) | $ | 21,228 | $ | 189,006 | $ | 17,550 | ||||||
Interest income relates to the interest earned on our cash and cash equivalents and short-term investments. We experienced a decrease over the prior year due to a decrease in the rate of interest earned. The loss on disposal of fixed assets relates to the closing of the Vestal, New York office and related disposal of office equipment and furniture.
Liquidity and Capital Resources
Our primary cash needs are for personnel, professional and development related fees and insurance. Our principal sources of liquidity are cash and cash equivalents and short-term investments. As of November 30, 2020 and August 31, 2020, we had cash and cash equivalents and short-term investments of $13,549,510 and $14,151,523, respectively. We have financed our operations primarily from the sale of equity and debt securities. We expect the cost of funding the South Korea office to be approximately $850,000 over the twelve months ending August 31, 2021.
The following table presents a summary of our cash flows for the periods indicated:
| Three Months Ended November 30, | 2021 compared to | |||||||||||
| 2020 | 2019 | 2020 | ||||||||||
| Net cash used in operating activities | $ | (579,314 | ) | $ | (648,468 | ) | $ | 69,154 | ||||
| Net cash used in investing activities | (5,025,565 | ) | (5,031 | ) | (5,020,534 | ) | ||||||
| Effect of exchange rate changes on cash and cash equivalents | 2,866 | 2,866 | ||||||||||
| Net (decrease) in cash and cash equivalents | $ | (5,602,013 | ) | $ | (653,499 | ) | $ | (4,948,514 | ) | |||
Operating Activities
Operating activities consist of net loss adjusted for certain non-cash items, including depreciation, non-cash lease expense, stock-based compensation expense, realized gains or losses on disposal of property and equipment, and the effect of working capital changes. The decrease over the prior period is mainly due to the increase in net loss, and the timing of accounts payable. The increase in net loss was primarily due to an increase in stock based compensation resulting from the grant of options to our CEO and South Korean subsidiary President, and higher personnel and SG&A costs partially offset by a decrease in professional fees.
| 18 |
Investing Activities
We have used cash primarily for short-term investments, investments in property and equipment, and, to a lesser extent, for the purchase of furniture and office equipment, including computers and software. Net investment activities for capital expenditures were $25,565 during the three months ended November 30, 2020, compared to $5,031 during the three months ended November 30, 2019. Also, during the three months ended November 30, 2020, we purchased a twelve month term deposit in the amount of $5,000,000.
Indebtedness
None.
Off-Balance Sheet Arrangements
We have no off-balance sheet arrangements.
Other Contractual Obligations
In September 2020, the Company, through its wholly owned subsidiaries, SolarWindow Asia (USA) Corp. and SolarWindow Asia Co., Ltd., entered a lease for office space in South Korea. The lease has a term of one year from September 23, 2020 through September 23, 2021 with monthly payments of approximately $1,200.
During fiscal 2019 the Company made payments totaling $1,292,655 towards the purchase of manufacturing equipment with an estimated total cost of $1,803,000. The remaining $510,345 will be paid upon the completion of the equipment once the final specifications have been determined pending optimization of the Company’s product iteration specific to this equipment. For additional information, see “Note 3 – Property and Equipment” located in the footnotes to our financial statements.
Recent accounting pronouncements not yet adopted
See Note 2 to our consolidated financial statements, “Summary of significant accounting policies – Recent accounting pronouncements not yet adopted.”
Recently adopted accounting pronouncements
See Note 2 to our consolidated financial statements, “Summary of significant accounting policies – Recently adopted accounting pronouncements.”
Critical Accounting Policies and Significant Judgments’ and Use of Estimates
Management’s discussion and analysis of financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these consolidated financial statements required the use of estimates and judgments that affect the reported amounts of our assets, liabilities, and expenses. Management bases estimates on historical experience and other assumptions it believes to be reasonable under the circumstances and evaluates these estimates on an on-going basis. Actual results may differ from these estimates. There have been no significant changes to the critical accounting policies and estimates included in our Annual Report on Form 10-K for the fiscal year ended August 31, 2020.
Related Party Transactions
See Note 7 to our consolidated financial statements for a discussion of our related party transactions.
| 19 |
Corporate Information
SolarWindow Technologies, Inc., a Nevada corporation, was incorporated in 1998. The Company’s executive offices are located at 430 Park Avenue, Suite 702, New York, NY 10022. The Company’s telephone number is (800) 213-0689. Our Internet address is www.solarwindow.com. We make available free of charge through our Internet website our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to the Securities Exchange Act of 1934, as amended, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the Securities and Exchange Commission (“SEC”). The information accessible through our website is not a part of this Quarterly Report on Form 10-Q.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily the result of fluctuations in interest rates and foreign currency exchange rates. We do not hold or issue financial instruments for trading purposes.
Item 4. Controls and Procedures
Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”), as of the end of the period covered by this quarterly report. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that as of November 30, 2020, that our disclosure controls and procedures were effective such that the information required to be disclosed in our SEC filings is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
| 20 |
PART II – OTHER INFORMATION
In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended August 31, 2020, which could materially affect our business, financial condition, financial results, or future performance. There have been no material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended August 31, 2020.
____________________
* Filed herewith
** Furnished herewith. XBRL (eXtensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.
| 21 |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| SolarWindow Technologies, Inc. | ||
| By: | /S/ Jatinder S. Bhogal | |
| Jatinder S. Bhogal | ||
| Chief Executive Officer | ||
| (Principal Financial Officer) | ||
| Date: | January 8, 2021 | |
| By: | /S/ Justin Frere, CPA | |
| Justin Frere, CPA | ||
| Interim Chief Financial Officer | ||
| (Principal Financial Officer) | ||
| Date: | January 8, 2021 | |
22